The Asian neurointerventional radiology device market is mainly driven by gradual technological evolution, growing aging and obese population, rising patient pool suffering from ischemic and hemorrhagic stroke, and increasing demand for minimally invasive surgical procedures. This market was valued at $125.5 million in 2012 and is expected to grow at a CAGR of 14.8% to reach $268.6 million by 2018.
The report on the Asian neurointerventional radiology device market analyzes the market under five segments by device: neurothrombectomy devices (suction/aspiration device, clot retriever, and snare device), cerebral angiography and stenting system (carotid stent and embolic protection system), aneurysm coiling devices (platinum coil, liquid embolic agents, and flow diversion device) and support devices (microcatheter and microguidewire). Neurothrombectomy devices and cerebral angiography markets have been witnessing maximum growth because of increase in patient pool and procedure numbers of aneurysm coiling, arteriovenous malformation embolization, and fistula embolization.
Procedure volume growth is significantly higher in the Latin American and Asia-Pacific market (India, China, and Japan). Both markets are expected to grow at a higher pace due to the effect of growing GDP and purchasing capability of healthcare institutions in these regions, fast disease progression, higher prevalence, broadening insurance coverage, expanding private healthcare sector, and increasing awareness amongst people. Coiling procedure and flow diversion have gained popularity in the Asia-Pacific and Latin American market.
The prevalence of ischemic and hemorrhagic stroke in North America and Europe is around 8-10% in the adult population whereas in Asia, it is around 12%. The high prevalence in Asia is because of maximum aging population whereas in North America and Europe it is because of diabetic and obese population.
This report also provides an extensive competitive landscape of companies operating in the Asian neurointerventional radiology devices market. The main companies covered in this report are Covidien plc (Ireland), Stryker Corporation (U.S.), Johnson & Johnson (U.S.), and Penumbra, Inc. (U.S.).
Segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of major companies have been detailed in the report.
Report Customization Options
Along with market data, you can also customize MMM offerings that are in keeping with your company’s specific needs. Customize your report on the Asian market for neurointerventional radiology devices to get an insight into all-inclusive industry standards and a deep-dive analysis of the following considerations:
Product Analysis
- Usage pattern (in-depth trend analysis) of products (segment wise)
- Product matrix which gives a detailed comparison of the product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of the products (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence of ischemic and hemorrhagic stroke
- Country-specific patient pool of ischemic and hemorrhagic stroke
- Disease progression (pattern analysis)
Procedure Volume Data
- Bilateral and unilateral neurointerventional procedures performed annually in each country tracked till sub-segment level
- Number of neurothrombectomy, cerebral balloon angioplasty, and stenting procedures performed in each country
Surgeon/Physician Perception analysis
- Fast turnaround analysis of surgeons’ response to market events and trends
- Pattern analysis of usage of aneurysm coiling, arteriovenous malformation embolization, and fistula embolization by physicians
- Surgeons’ opinion about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/Product Perception Matrix
- Comprehensive study of customer perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of the neurointerventional radiology devices in Asia
- Procedural investment in neurothrombectomy, cerebral balloon angioplasty, and stenting for the Asian region
Competitive Intelligence
- Company share analysis of top players in the Asian market
- Crucial developments and strategies companies are implementing in order to grow in this market
1 Introduction
1.1 Objective of the study
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
1.4.1 Assumptions (Market Size, Forecast, etc)
2 Executive Summary
3 Market Overview
4 Neurointerventional Devices-Asia, By Products
4.1 Neurothrobectomy Devices-Asia
4.1.1 Neurothrobectomy Devices-Asia, By Subproducts
4.1.1.1 Suction/Aspiration Device-Asia
4.1.1.2 Clot Retriever-Asia
4.1.1.3 Snare Devices-Asia
4.2 Cerebral Ballon Angioplasty & Stenting Sytems-Asia
4.2.1 Cerebral Ballon Angioplasty & Stenting Sytems-Asia, By Products
4.2.1.1 Carotid Artery Stents-Asia
4.2.1.2 Embolic Protection Systems-Asia
4.3 Embolization Devices-Asia
4.3.1 Embolization Devices-Asia, By Products
4.3.1.1 Flow Diversion Devices-Asia
4.3.1.2 Embolic Coil-Asia
4.3.1.3 Liquid Embolic Agents-Asia
4.4 Support Devices-Asia
4.4.1 Support Devices-Asia, By Products
4.4.1.1 Microcatheters-Asia
4.4.1.2 Microguidewires-Asia
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement